Wang, Liang <br/><br/>
Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Sep 2012 
 - 2153-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-011-0049-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Cyclophosphamide<br/>Doxorubicin<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Immunotherapy<br/>Kaplan-Meier Estimate<br/>Luminescent Measurements<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Phosphopyruvate Hydratase--blood<br/>Prednisone<br/>Prognosis<br/>Proportional Hazards Models<br/>Rituximab<br/>Treatment Outcome<br/>Vincristine